NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) major shareholder Financial Lp Hrt purchased 27,993 shares of the business’s stock in a transaction dated Tuesday, May 26th. The shares were acquired at an average price of $0.92 per share, for a total transaction of $25,753.56. Following the acquisition, the insider directly owned 139,878 shares in the company, valued at $128,687.76. This represents a 25.02% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Financial Lp Hrt also recently made the following trade(s):
- On Friday, May 22nd, Financial Lp Hrt purchased 137,541 shares of NewGenIvf Group stock. The shares were acquired at an average price of $0.99 per share, for a total transaction of $136,165.59.
NewGenIvf Group Stock Performance
NewGenIvf Group stock opened at $0.85 on Thursday. NewGenIvf Group Limited has a 1-year low of $0.72 and a 1-year high of $1,839.00. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. The firm’s fifty day simple moving average is $1.68 and its 200-day simple moving average is $6.93.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.
Read Our Latest Research Report on NewGenIvf Group
About NewGenIvf Group
NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.
NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.
Further Reading
- Five stocks we like better than NewGenIvf Group
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.
